PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS
DEAD

Serial Number

79266965

Owner

PLATBIO Inc.

Filing Date

May 22, 2019

Add to watchlist:

No watchlists yet
View on USPTO

PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS Trademark

Serial Number: 79266965

PRINT PLATFORM FOR REVOLUTIONARY IDENTIFICATION & ISOLATION OF NOVEL TARGETS is a trademark filed by PLATBIO Inc. on May 22, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

PLATBIO Inc. (2 trademarks)

15F, 91, Changnyong-daero 256 beon-gil,

Entity Type: 03

Trademark Details

Filing Date

May 22, 2019

Registration Date

Not Registered

Goods & Services

Pharmaceutical products for the treatment of viral diseases; anti-inflammatory analgesic preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; capsules for medicines; gastro-intestinal treatment preparations; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; medical diagnostic test strips; diagnostic test reagents for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medicinal use; pharmaceuticals; clinical diagnostic reagents; pharmaceutical preparations for use in the targeted therapy of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for use in oncology; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis; radio-isotope markers for therapeutic or diagnostic use; therapeutic drugs and agents; dermatological pharmaceutical products; tumor suppressing agents; pharmaceutical preparations for respiratory organs

Research and development of vaccines and medicines; drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical products development; research on the subject of pharmaceuticals; pharmaceutical products evaluation; pharmaceutical drug development services; medicine research; medical product testing; laboratory research services relating to pharmaceuticals; research in the field of medical products; consultancy in the field of testing, inspection, research of medical products; providing information on the testing, inspection, research of medical products; scientific research in the fields of medicine, health and pharmacology; consultation and providing information in the field of pharmacology; analysis and evaluation of medical product development; research in the field of target identification of tumors; research and development services in the field of medical preparations and technology for targeted therapy of tumors; research in the field of diagnostic target identification

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 4, 2021 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Jun 14, 2021 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 12, 2021 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 2, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 14, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 14, 2021 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jun 12, 2020 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jun 12, 2020 ABN2
ATTORNEY REVIEW COMPLETED
Nov 26, 2019 ATRV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Nov 20, 2019 CREV
USPTO CORRECTION PROCESSED BY IB
Nov 15, 2019 RINX
CORRECTION TRANSACTION RECEIVED FROM IB
Nov 15, 2019 CRCV
REFUSAL PROCESSED BY IB
Nov 9, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 13, 2019 RFCS
REFUSAL PROCESSED BY MPU
Oct 12, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 4, 2019 RFCR
NON-FINAL ACTION WRITTEN
Oct 3, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Sep 20, 2019 MAFR
ASSIGNED TO EXAMINER
Sep 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 12, 2019 REPR